SCHEMBL1078274

SCHEMBL1078274

O=C(CI)O[N+]1(O)C(=O)CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3517149 0.83
SCHEMBL781569 0.81 TRPA1 (0.33)
SCHEMBL19549311 0.79 TSHR (0.34)
SCHEMBL1177488 0.79
SCHEMBL10972293 0.76
Hydrogen Sulfide SCHEMBL8530806 0.75
SCHEMBL1505284 0.73 TSHR (0.42)
SCHEMBL15110455 0.73
SCHEMBL5785547 0.71
SCHEMBL515929 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025077330-A1 SILICA MICROSPHERE COMPOSITE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海领检科技有限公司 2025-04-17 WO claimed
WO-2022198925-A1 NANO-MAGNETIC BEAD COATING, AND PREPARATION METHOD THEREFOR, DETECTION REAGENT THEREOF AND DETECTION KIT THEREOF 深圳市亚辉龙生物科技股份有限公司 2022-09-29 WO claimed
CN-113049811-A Nano magnetic bead coating material, preparation method thereof, detection reagent and detection kit 深圳市亚辉龙生物科技股份有限公司 2021-06-29 CN claimed
CN-111565707-A Devices and methods for delivering therapeutics 森玛治疗公司 2020-08-21 CN claimed
EP-3638205-A1 DEVICES AND METHODS FOR DELIVERING THERAPEUTICS Semma Therapeutics, Inc. (US) 2020-04-22 EP claimed
WO-2018232180-A1 DEVICES AND METHODS FOR DELIVERING THERAPEUTICS SEMMA THERAPEUTICS, INC. (US) 2018-12-20 WO claimed
US-20100022013-A1 DIRECT MASS SPECTROMETRIC ANLAYSIS OF AGGREGATES OF THERAPEUTIC PROTEINS COVALX AG (CH) 2010-01-28 US claimed
US-20050059137-A1 Bio-support and preparing method of the same MACROGEN INC. (KR) 2005-03-17 US claimed
WO-2002033412-A1 BIO-SUPPORT AND PREPARING METHOD OF THE SAME MACROGEN INC. (KR) 2002-04-25 WO claimed
US-12630948-B2 Foamable yarns, textiles and articles incorporating foamable yarns, and the process of manufacturing the same NIKE, INC. (US) 2026-05-19 US disclosed
EP-4004548-B1 METHODS OF TREATING AND DIAGNOSING LUNG CANCER YEDA RES & DEV (IL) 2026-01-14 EP disclosed
US-20250354993-A1 METHODS OF TREATING AND DIAGNOSING LUNG CANCER YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2025-11-20 US disclosed
US-12448647-B2 Methods of monitoring a reaction PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2025-10-21 US disclosed
EP-4629967-A1 PERFLUORINATED MICELLES AND MEDICAL USES THEREOF Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) 2025-10-15 EP disclosed
WO-1993003736-A1 CROSS-LINKING OLIGONUCLEOTIDES FOR ENZYME-MEDIATED TRIPLE STRAND FORMATION MICROPROBE CORPORATION (US) 1993-03-04 WO disclosed
WO-1992007268-A1 HOMOBIFUNCTIONAL AGENTS FOR COUPLING ENZYMES AND THE LIKE TO ANTIBODIES AND THE LIKE ABBOTT LABORATORIES (US) 1992-04-30 WO disclosed
US-5095097-A Diagnostics BEHRINGWERKE AKTIENGESELLSCHAFT (DE) 1992-03-10 US disclosed
US-4438030-A Antibodies to immunogenic peptides and their use to purify human fibroblast interferon E. I. DU PONT DE NEMOURS AND COMPANY (US) 1984-03-20 US disclosed
US-4341761-A Antibodies to immunogenic peptides and their use to purify human fibroblast interferon E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-07-27 US disclosed
US-4311639-A Immunogenic interferon peptides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-01-19 US disclosed